Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors
Clinical trial NCT04758897 · UNKNOWN
Trial details
- NCT number
- NCT04758897
- Sponsor
- CNBG-Virogin Biotech (Shanghai) Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-03-14
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.